SecBot SecBot
144 ·Filed Nov 9, 2026

ABBV

AbbVie Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed7d 6h ago SEC0001950047-26-010822
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine insider sale notice tied to a same-day option exercise, likely for tax or diversification purposes. The amount is immaterial relative to AbbVie's market cap. Monitor for the actual Form 4 filing to confirm execution, but no significant market impact is expected.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$293.89
T+0 close · Nov 9, 2026 · via day close
Latest settled
+0.37%
T+1 · $294.98
Vs SPY
−0.95%
α at T+1
Next horizon
T+5
in 9h
  1. T+0 · Nov 10 $293.89entry
  2. T+1 · 6d ago +0.37%α −0.95% · $294.98
  3. T+4 · todayOpen
  4. T+5 · in 9h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Jeffrey R. Stewart, an officer of AbbVie, filed a Form 144 notice of intent to sell 40,619 shares of common stock, with an approximate market value of $11.9 million based on the filing date. The shares were acquired through a stock option exercise on the same day, and the sale is planned for execution on or after November 9, 2026.

Key Facts

  • Reporting person: Jeffrey R. Stewart, an officer of AbbVie Inc.
  • Shares to be sold: 40,619 shares of common stock
  • Approximate dollar value: $11,925,848.07
  • Shares acquired via stock option exercise on 11/09/2026
  • Proposed sale date: 11/09/2026
  • Broker: Morgan Stanley Smith Barney LLC Executive Financial Services

Financial Impact

Sale of 40,619 shares valued at approximately $11.9 million, representing about 0.002% of AbbVie's $510.3B market cap

dilution

Risk Factors

  • Form 144 is an intent to sell; the sale may not be executed
  • Insider sales around option exercises are common and typically not indicative of negative outlook

Market Snapshot

Price
$293.34
Volume
299
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (38 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010822
Document: 0001950047-26-010822-index.html0001950047-26-010822
Document: 0001950047-26-010822.txt0001950047-26-010822

Track record

22 reports on ABBV

Performance horizon

7 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +27.21% at T+60 after the Apr 29, 2026 report. 7 of 9 went positive at some point.

Filters
  1. Nov 9, 20267d ago 144 Neutral 2/10 Viewing Entry $293.89 Now $294.55 +0.22% settles Dec 9
  2. Nov 2, 202614d ago 8-K Neutral 2/10 Entry $286.00 Now $294.55 +2.99% settles Dec 2
  3. Oct 30, 202617d ago 8-K Bullish 6/10 Entry $294.89 Now $294.55 −0.12% settles Nov 30
  4. Oct 29, 202619d ago Court Ruling Bullish 7/10 Entry $294.89 Now $294.55 −0.12% settles Nov 30
  5. Oct 16, 20264w ago Institutional Cluster Bullish 4/10 Entry $282.68 to $294.55 Now $294.55 +4.20% ▲ +4.20% +7.66% vs SPY
  6. Oct 15, 20264w ago 8-K Neutral 2/10 Entry $285.42 to $295.03 Now $294.55 +3.20% ▲ +3.37% +4.53% vs SPY
  7. Oct 5, 20266w ago 8-K Neutral 4/10 Entry $265.06 to $289.60 Now $294.55 +11.12% ▲ +9.26% +12.16% vs SPY
  8. Sep 28, 20267w ago Court Ruling Neutral 2/10 Entry $263.29 to $286.39 Now $294.55 +11.87% ▲ +8.77% +8.06% vs SPY
  9. Sep 14, 20269w ago Court Ruling Neutral Not scored Entry $261.43 to $272.69 Now $294.55 +12.67% ▲ +4.30% +1.33% vs SPY
  10. Sep 3, 202610w ago 8-K Neutral 4/10 Entry $260.21 to $262.82 Now $294.55 +13.20% ▲ +1.00% +2.19% vs SPY
Showing 10 of 22

US Market Status

Market Closed · Opens Wed (11h 3m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 9, 2026